West Nile virus: Epidemiology and clinical features of an emerging epidemic in the United States

Annual Review of Medicine

Volumn 57, Issue , 2006, Pages 181-194

  Hayes, Edward B ^a   Gubler, Duane J ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Encephalitis; Pathogenesis; Prevention; Treatment

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGONUCLEOTIDE; CORTICOSTEROID; IMMUNOGLOBULIN; INACTIVATED VACCINE; LIVE VACCINE; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; WEST NILE VACCINE;

CANADA; CENTRAL AMERICA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ENCEPHALITIS; EPIDEMIC; HEALTH SURVEY; HUMAN; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOUTH AND CENTRAL AMERICA; UNITED STATES; WEST NILE FLAVIVIRUS;

DISEASE OUTBREAKS; HUMANS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 32944469306     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.57.121304.131418     Document Type: Review

References (109)

1. Smithburn KC, Hughes TP, Burke AW, et al. 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. 20:471-92
2. Hayes CG. 1989. West Nile fever. In The Arboviruses: Epidemiology and Ecology, ed. TP Monath, pp. 59-88. Boca Raton, FL: CRC
3. Russell RC, Dwyer DE. 2000. Arboviruses associated with human disease in Australia. Microbes Infect. 2:1693-704
4. Tsai TF, Popovici F, Cernescu C, et al. 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet 352:767-71
5. Nash D, Mostashari F, Fine A, et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:1807-14
6. 5a. Hayes EB, Komar N, Nasci RS, et al. 2005. Epidemiology and dynamics of transmission of West Nile virus disease. Emerg. Infect. Dis. 11:1167-73
7. 5b. Mattar S, Edwards E, Laguado J, et al. 2005. West Nile virus antibodies in Colombian horses. Emerg. Infect. Dis. 11(9): Epub ahead of print. Accessed 8/16/05, http://www.cdc.gov/ncidod/EID/vol11no 09/05-0426.htm
8. McIntosh BM, Jupp PG, Dos Santos I, et al. 1976. Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector. S. Afr. J. Sci. 72:295-300
9. Mostashari F, Bunning ML, Kitsutani PT, et al. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358:261-64
10. Centers for Disease Control and Prevention. 2001. Serosurveys for West Nile virus infection-New York and Connecticut counties, 2000. Morb. Mortal. Wkly. Rep. 50:37-39
11. Komar N. 2003. West Nile virus: epidemiology and ecology in North America. Adv. Virus Res. 61:185-234
12. Turell MJ, O'Guinn ML, Dohm DJ, et al. 2001. Vector competence of North American mosquitoes (Diptera: Culicidae) for West Nile virus. J. Med. Entomol. 38:130-34
13. Goddard LB, Roth AE, Reisen WK, et al. 2002. Vector competence of California mosquitoes for West Nile virus. Emerg. Infect. Dis. 8:1385-91
14. Turell MJ, Dohm DJ, Sardelis MR, et al. 2005. An update on the potential of North American mosquitoes (Diptera: Culicidae) to transmit West Nile Virus. J. Med. Entomol. 42:57-62
15. Dohm DJ, Sardelis MR, Turell MJ. 2002. Experimental vertical transmission of West Nile virus by Culexpipiens (Diptera: Culicidae). J. Med. Entomol. 39:640-44
16. Nasci RS, Savage HM, White DJ, et al. 2001. West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg. Infect. Dis. 7:742-44
17. Komar N, Langevin S, Hinten S, et al. 2003. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg. Infect. Dis. 9:311-22
18. Rappole JH, Hubalek Z. 2003. Migratory birds and West Nile virus. J. Appl. Microbiol. 94(Suppl.):S47-58
19. Peterson AT, Vieglais DA, Andreasen JK. 2003. Migratory birds modeled as critical transport agents for West Nile Virus in North America. Vector Borne Zoonotic Dis. 3:27-37
20. Klenk K, Snow J, Morgan K, et al. 2004. Alligators as West Nile virus amplifiers. Emerg. Infect. Dis. 10:2150-55
21. Bunning ML, Bowen RA, Cropp CB, et al. 2002. Experimental infection of horses with West Nile virus. Emerg. Infect. Dis. 8:380-86
22. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, et al. 2004. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 189:669-76
23. O'Leary DR, Marfin AA, Montgomery SP, et al. 2004. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis. 4:61-70
24. Kumar D, Drebot MA, Wong SJ, et al. 2004. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am. J. Transplant. 4:1883-88
25. Kumar D, Prasad GV, Zaltzman J, et al. 2004. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 77:399-402
26. Burton JM, Kern RZ, Halliday W, et al. 2004. Neurological manifestations of West Nile virus infection. Can. J. Neurol. Sci. 31:185-93
27. Fan E, Needham DM, Brunton J, et al. 2004. West Nile virus infection in the intensive care unit: a case series and literature review. Can. Respir. J. 11:354-58
28. Li J, Loeb JA, Shy ME, et al. 2003. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann. Neurol. 53:703-10
29. Haley M, Retter AS, Fowler D, et al. 2003. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin. Infect. Dis. 37:e88-90
30. Han LL, Popovici F, Alexander JP Jr., et al. 1999. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J. Infect. Dis. 179:230-33
31. Chowers MY, Lang R, Nassar F, et al. 2001. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg. Infect. Dis. 7:675-78
32. Ceccaldi PE, Lucas M, Despres P. 2004. New insights on the neuropathology of West Nile virus. FEMS Microbiol. Lett. 233:1-6
33. Perelygin AA, Scherbik SV, Zhulin IB, et al. 2002. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. USA 99:9322-27
34. Pealer LN, Marfin AA, Petersen LR, et al. 2003. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349:1236-45
35. Iwamoto M, Jernigan DB, Guasch A, et al. 2003. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl. J. Med. 348:2196-203
36. Alpert SG, Fergerson J, Noel LP. 2003. Intrauterine West Nile virus: ocular and systemic findings. Am. J. Ophthalmol. 136:733-35
37. Centers for Disease Control and Prevention. 2002. Possible West Nile virus transmission to an infant through breastfeeding-Michigan, 2002. Morb. Mortal. Wkly. Rep. 51:877-78
38. 2002. Laboratory-acquired West Nile virus infections-United States, 2002. Morb. Mortal. Wkly. Rep. 51:1133-35
39. 2003. West Nile virus infection among turkey breeder farm workers-Wisconsin, 2002. Morb. Mortal. Wkly. Rep. 52:1017-19
40. 2004. Possible dialysis-related West Nile virus transmission-Georgia, 2003. Morb. Mortal. Wkly. Rep. 53:738-39
41. Mackenzie JS, Gubler DJ, Petersen LR. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:898-109
42. Brinton MA. 2002. The molecular biology of West Nile virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 56:371-402
43. Lanciotti RS, Ebel GD, Deubel V, et al. 2002. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298:96-105
44. Beasley DW, Davis CT, Whiteman M, et al. 2004. Molecular determinants of virulence of West Nile virus in North America. Arch. Virol. Suppl. 35-41
45. Brault AC, Langevin SA, Bowen RA, et al. 2004. Differential virulence of West Nile strains for American crows. Emerg. Infect. Dis. 10:2161-68
46. Langevin SA, Brault AC, Panella NA, et al. 2005. Variation in virulence of West Nile virus strains for house sparrows (Passer domestic us). Am. J. Trop. Med. Hyg. 72:99-102
47. Beasley DW. 2004. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg. Infect. Dis. 10:2221-24
48. Davis CT, Beasley DW, Guzman H, et al. 2004. Emergence of attenuated West Nile virus variants in Texas, 2003. Virology 330:342-50
49. Diamond MS, Shrestha B, Mehlhop E, et al. 2003. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16:259-78
50. Wang T, Town T, Alexopoulou L, et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-73
51. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. 2004. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch. Neurol. 61:1210-20
52. Guarner J, Shieh WJ, Hunter S, et al. 2004. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum. Pathol. 35:983-90
53. Darman J, Backovic S, Dike S, et al. 2004. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J. Neurosci. 24:7566-75
54. Wang T, Fikrig E. 2004. Immunity to West Nile virus. Curr. Opin. Immunol. 16:519-23
55. Leis AA, Stokic DS. 2005. Neuromuscular manifestations of human West Nile virus infection. Curr. Treat. Options Neurol. 7:15-22
56. Jeha LE, Sila CA, Lederman RJ. 2003. West Nile virus infection: a new acute paralytic illness. Neurology 61:55-59
57. Kelley TW, Prayson RA, Ruiz AI, et al. 2003. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am. J. Clin. Pathol. 119:749-53
58. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-34
59. Watson JT, Pertel PE, Jones RC, et al. 2004. Clinical characteristics and functional outcomes of West Nile Fever. Ann. Intern. Med. 141:360-65
60. Marberg K, Goldblum N, Sterk VV, et al. 1956. The natural history of West Nile fever. I. Clinical observations during an epidemic in Israel. Am. J. Hygiene. 64:259-69
61. Georges AJ, Lesbordes JL, Georges-Courbot MC, et al. 1987. Fatal hepatitis from West Nile virus. Ann. Inst. Pasteur Virol. 138:237-44
62. Perelman A, Stern J. 1974. Acute pancreatitis in West Nile Fever. Am. J. Trop. Med. Hyg. 23:1150-52
63. Platonov AE, Shipulin GA, Shipulina OY, etal. 2001. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg. Infect. Dis. 7:128-32
64. Kulstad EB, Wichter MD. 2003. West Nile encephalitis presenting as a stroke. Ann. Emerg. Med. 41:283
65. 62a. Montgomery SP, Chow CC, Smith SW, et al. 2005. Rhabdomyolysis in patients with West Nile encephalitis and meningitis. Vector Borne Zoonotic Dis. In press
66. Smith RD, Konoplev S, DeCourten-Myers G, et al. 2004. West Nile virus encephalitis with myositis and orchitis. Hum. Pathol. 35:254-58
67. Anninger WV, Lomeo MD, Dingle J, et al. 2003. West Nile virus-associated optic neuritis and chorioretinitis. Am. J. Ophthalmol. 136:1183-85
68. Bains HS, Jampol LM, Caughron MC, et al. 2003. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch. Ophthalmol. 121:205-7
69. Kuchtey RW, Kosmorsky GS, Martin D, et al. 2003. Uveitis associated with West Nile virus infection. Arch. Ophthalmol. 121:1648-49
70. Khairallah M, Ben Yahia S, Ladjimi A, et al. 2004. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 111:2065-70
71. Ceausu E, Erscoiu S, Calistru P, et al. 1997. Clinical manifestations in the West Nile virus outbreak. Rom. J. Virol. 48:3-11
72. Sejvar JJ, Haddad MB, Tierney BC, et al. 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511-15
73. Pepperell C, Rau N, Krajden S, et al. 2003. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. Can. Med. Assoc. J. 168:1399-405
74. Asnis DS, Conetta R, Teixeira AA, et al. 2000. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin. Infect. Dis. 30:413-18
75. Weiss D, Carr D, Kellachan J, et al. 2001. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg. Infect. Dis. 7:654-58
76. Emig M, Apple DJ. 2004. Severe West Nile virus disease in healthy adults. Clin. Infect. Dis. 38:289-92
77. Sayao AL, Suchowersky O, Al-Khathaami A, et al. 2004. Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. Can. J. Neurol. Sci. 31:194-203
78. Sejvar JJ, Leis AA, Stokic DS, et al. 2003. Acute flaccid paralysis and West Nile virus infection. Emerg. Infect. Dis. 9:788-93
79. Leis AA, Stokic DS, Webb RM, et al. 2003. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 28:302-8
80. Al-Shekhlee A, Katirji B. 2004. Electrodiagnostic features of acute paralytic poliomyelitis associated with West Nile virus infection. Muscle Nerve 29:376-80
81. Ahmed S, Libman R, Wesson K, et al. 2000. Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology 55:144-46
82. Tyler KL. 2004. West Nile virus infection in the United States. Arch. Neurol. 61:1190-95
83. 79a. Procop GW, Yen-Lieberman B, Prayson RA, Gordon SM. 2004. Mollaret-like cells in patients with West Nile virus infection. Emerg. Infect. Dis. 10:753-54
84. Cunha BA, McDermott BP, Mohan SS. 2004. Prognostic importance of lymphopenia in West Nile encephalitis. Am. J. Med. 117:710-11
85. Cunha BA, Sachdev B, Canario D. 2004. Serum ferritin levels in West Nile encephalitis. Clin. Microbiol. Infect. 10:184-86
86. Martin DA, Biggerstaff BJ, Allen B, et al. 2002. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin. Diagn. Lab. Immunol. 9:544-49
87. Lanciotti RS, Kerst AJ, Nasci RS, et al. 2000. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol. 38:4066-71
88. Klee AL, Maidin B, Edwin B, et al. 2004. Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis. 10:1405-11
89. Marciniak C, Sorosky S, Hynes C. 2004. Acute flaccid paralysis associated with West Nile virus: motor and functional improvement in 4 patients. Arch. Phys. Med. Rehabil. 85:1933-38
90. Flaherty ML, Wijdicks EF, Stevens JC, et al. 2003. Clinical and electrophysiologic patterns of flaccid paralysis due to West Nile virus. Mayo Clin. Proc. 78:1245-48
91. Ali M, Safriel Y, Sohi J, et al. 2005. West Nile virus infection: MR imaging findings in the nervous system. Am. J. Neuroradiol. 26:289-97
92. Diamond MS, Klein RS. 2004. West Nile virus: crossing the blood-brain barrier. Nat. Med. 10:1294-95
93. Gubler DJ, Campbell GL, Nasci R, et al. 2000. West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol. 13:469-75
94. Shapiro H, Micucci S. 2003. Pesticide use for West Nile virus. Can. Med. Assoc. J. 168:1427-30
95. Fradin MS, Day JF. 2002. Comparative efficacy of insect repellents against mosquito bites. N. Engl. J. Med. 347:13-18
96. Koren G, Matsui D, Bailey B. 2003. DEET-based insect repellents: safety implications for children and pregnant and lactating women. Can. Med. Assoc. J. 169:209-12
97. Bell JW, Veltri JC, Page BC. 2002. Human exposure to N,N-diethyl-m- toluamide insect repellents reported to the American Association of Poison Control Centers 1993-1997. Int. J. Toxicol. 21:341-52
98. Barnard DR, Xue RD. 2004. Laboratory evaluation of mosquito repellents against Aedes albopictus, Culex nigripalpus, and Ochierotatus triseriatus (Diptera: Culicidae). J. Med. Entomol. 41:726-30
99. 94a. Fradin MS. 1998. Mosquitoes and mosquito repellents: a clinician's guide. Ann. Intern. Med. 128:931-40
100. Custer B, Tomasulo PA, Murphy EL, et al. 2004. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion (Paris) 44:1547-54
101. Kiberd BA, Forward K. 2004. Screening for West Nile virus in organ transplantation: a medical decision analysis. Am. J. Transplant. 4:1296-301
102. Ng T, Hathaway D, Jennings N, et al. 2003. Equine vaccine for West Nile virus. Dev. Biol. (Basel) 114:221-27
103. Minke JM, Siger L, Karaca K, et al. 2004. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 221-30
104. Hall RA, Khromykh AA. 2004. West Nile virus vaccines. Expert Opin. Biol. Ther. 4:1295-305
105. Yamshchikov G, Borisevich V, Seregin A, et al. 2004. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development. Virology 330:304-12
106. Tesh RB, Arroyo J, Travassos Da Rosa AP, et al. 2002. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis. 8:1392-97
107. Pletnev AG, Claire MS, Elkins R, et al. 2003. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314:190-95
108. Chang GJ, Kuno G, Purdy DE, et al. 2004. Recent advancement in flavivirus vaccine development. Expert Rev. Vaccines 3:199-220
109. Despres P, Combredet C, Frenkiel MP, et al. 2005. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J. Infect. Dis. 191:207-14